Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 10
2022 8
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
"If I have Sjögren's syndrome, I want to know it as early as possible": The perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey.
Alunno A, Carubbi F, Ritschl V, Cornec D, Zenz S, Vieira A, Antonopoulou K, Chatzis L, Romão VC, Tzioufas A, Bandeira M, Stradner MH. Alunno A, et al. Among authors: chatzis l. Joint Bone Spine. 2024 Jan 28;91(4):105695. doi: 10.1016/j.jbspin.2024.105695. Online ahead of print. Joint Bone Spine. 2024. PMID: 38290661 No abstract available.
Sjögren's syndrome: one year in review 2023.
Longhino S, Chatzis LG, Dal Pozzolo R, Peretti S, Fulvio G, La Rocca G, Navarro Garcia IC, Orlandi M, Quartuccio L, Baldini C, Bartoloni E. Longhino S, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2023 Dec;41(12):2343-2356. doi: 10.55563/clinexprheumatol/255qsx. Epub 2023 Dec 23. Clin Exp Rheumatol. 2023. PMID: 38149515 Free article. Review.
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Desvaux E, Hemon P, Soret P, Le Dantec C, Chatzis L, Cornec D, Devauchelle-Pensec V; PRECISESADS clinical consortium; Elouej S, Duguet F, Laigle L, Poirier N, Moingeon P, Bretin S, Pers JO. Desvaux E, et al. Among authors: chatzis l. J Autoimmun. 2023 Dec 18:103147. doi: 10.1016/j.jaut.2023.103147. Online ahead of print. J Autoimmun. 2023. PMID: 38114349
The Role of the Akt Signaling Pathway in Sjögren's Syndrome.
Kapsogeorgou EK, Stergiou IE, Chatzis L, Voulgarelis M, Vlachoyiannopoulos PG. Kapsogeorgou EK, et al. Among authors: chatzis l. Mediterr J Rheumatol. 2023 Mar 31;34(1):113-116. doi: 10.31138/mjr.34.1.113. eCollection 2023 Mar. Mediterr J Rheumatol. 2023. PMID: 37223600 Free PMC article.
The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.
Stergiou IE, Chatzis LG, Pezoulas VC, Baldini C, Fotiadis DI, Voulgarelis M, Tzioufas AG, Goules AV. Stergiou IE, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2022 Dec;40(12):2357-2362. doi: 10.55563/clinexprheumatol/263xbc. Epub 2022 Dec 20. Clin Exp Rheumatol. 2022. PMID: 36541237 Free article.
Sjögren's syndrome: one year in review 2022.
Manfrè V, Chatzis LG, Cafaro G, Fonzetti S, Calvacchi S, Fulvio G, Navarro Garcia IC, La Rocca G, Ferro F, Perricone C, Bartoloni E, Baldini C. Manfrè V, et al. Among authors: chatzis lg. Clin Exp Rheumatol. 2022 Dec;40(12):2211-2224. doi: 10.55563/clinexprheumatol/43z8gu. Epub 2022 Dec 20. Clin Exp Rheumatol. 2022. PMID: 36541236 Free article. Review.
29 results